Neuroscience News and Research

RSS

Scientists open door to significantly improved treatments for multiple sclerosis

A team of basic and clinical scientists led by the University of Montreal Hospital* Research Centre's Dr. Nathalie Arbour has opened the door to significantly improved treatments for the symptoms of Multiple Sclerosis.

20 Mar 2013

Study shows worsened cognitive status associated with faster decline in functional abilities

More symptoms of depression and lower cognitive status are independently associated with a more rapid decline in the ability to handle tasks of everyday living, according to a study by Columbia University Medical Center researchers in this month's Journal of Alzheimer's Disease.

20 Mar 2013

New app to evaluate sports concussion

The American Academy of Neurology, the world's largest association of neurologists who treat brain injuries such as concussion, has launched a new app called "Concussion QuickCheck", to help coaches, athletic trainers, parents and athletes quickly evaluate if someone may have a concussion and needs to see a licensed health care provider, such as a neurologist, who is specialized in concussion.

19 Mar 2013

Study challenges role of serotonin in depression, opens possibilities for new therapies

A new study from the University of Maryland School of Medicine suggests that depression results from a disturbance in the ability of brain cells to communicate with each other.

19 Mar 2013

Neuroscientists explain why some people with autism cannot recognize faces

Neuroscientists at Georgetown University Medical Center have discovered a brain anomaly that explains why some people diagnosed with autism cannot easily recognize faces - a deficit linked to the impairments in social interactions considered to be the hallmark of the disorder.

19 Mar 2013

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

The following research from Columbia University Medical Center and NewYork-Presbyterian Hospital is being presented at the 65th annual meeting of the American Academy of Neurology, March 16-23, 2013, in San Diego.

18 Mar 2013

Discovery could lead to new target for treatment of cocaine addiction

Scientists have discovered a molecular process in the brain triggered by cocaine use that could provide a target for treatments to prevent or reverse addiction to the drug.

16 Mar 2013

Telestroke programs improve access to life-saving stroke care

Telestroke programs substantially improve access to life-saving stroke care, extending coverage to less populated areas in an effort to reduce disparities in stroke care access.

16 Mar 2013

Alzheimer's research demonstrates cell-to-cell transmission of neurodegenerative proteins

Injecting synthetic tau fibrils into animal models induces Alzheimer's-like tau tangles and imitates the spread of tau pathology, according to research from the Perelman School of Medicine at the University of Pennsylvania being presented at the American Academy of Neurology's 65th Annual Meeting in San Diego March 16-23, 2013.

16 Mar 2013

Luminex collaborates with Merck to design companion diagnostic device for Alzheimer’s disease

WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).

From Luminex 15 Mar 2013

Promising studies for Parkinson's to be presented at 65th AAN meeting

Three studies released today present possible positive news for people with Parkinson's disease. The studies, which will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013, report on treatments for blood pressure problems, the wearing-off that can occur when people have taken the main drug for Parkinson's for a long time, and for people early in the disease whose symptoms are not well-controlled by their main drugs.

15 Mar 2013

New hunt for intrinsic mechanism linked to schizophrenia

Since the 1960s, psychiatrists have been hunting for substances made by the body that might accumulate in abnormally high levels to produce the symptoms associated with schizophrenia. In particular, there was a search for chemicals that might be related to the hallucinogens phencyclidine (PCP) or lysergic acid diethylamide (LSD), which could explain the emergence of psychotic symptoms in schizophrenia.

15 Mar 2013

Researchers show inhibiting brain's filter can boost performance for tasks

The brain's prefrontal cortex is thought to be the seat of cognitive control, working as a kind of filter that keeps irrelevant thoughts, perceptions and memories from interfering with a task at hand.

15 Mar 2013

Max Planck Florida Institute for Neuroscience gets grant for research into neurological disorders

The Max Planck Florida Institute for Neuroscience, the first and only U.S. extension of the prestigious Max Planck Society, today announced it has received approximately $1,257,500 in grant funding from prestigious national and international organizations to fund research into Parkinson-s, epilepsy and other neurological disorders.

15 Mar 2013

Prescribing attention-boosting drugs for healthy kids is misguided

The American Academy of Neurology (AAN), the world's largest professional association of neurologists, is releasing a position paper on how the practice of prescribing drugs to boost cognitive function, or memory and thinking abilities, in healthy children and teens is misguided.

14 Mar 2013

UH Case Medical Center joins elite group of providers focused on complex stroke care

University Hospitals (UH) Case Medical Center has become the first hospital in Northeast Ohio and 19th in the nation to achieve The Joint Commission's standards for Comprehensive Stroke Center Certification, joining an elite group of providers focused on complex stroke care.

14 Mar 2013

GABA neuronal deficits in psychiatric disorder can be prevented using N-acetylcysteine: Study

Gamma-aminobutyric acid (GABA) deficits have been implicated in schizophrenia and depression. In schizophrenia, deficits have been particularly well-described for a subtype of GABA neuron, the parvalbumin fast-spiking interneurons.

14 Mar 2013

Stimulating brain using magnetic stimulation may improve cognitive function, say scientists

Cognitive impairments are disabling for individuals with schizophrenia, and no satisfactory treatments currently exist. These impairments affect a wide range of cognition, including memory, attention, verbal and motor skills, and IQ.

14 Mar 2013

Brain imaging can detect tiny lesions that may provide target for treating people with mTBI: Study

Brain imaging soon after mild traumatic brain injury or mild concussion can detect tiny lesions that may eventually provide a target for treating people with mTBI, according to a study released today and that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

13 Mar 2013

Biomedical professor details research progress toward reading, writing neural code

Despite many remarkable discoveries in the field of neuroscience during the past several decades, researchers have not been able to fully crack the brain's "neural code."

13 Mar 2013

Neuroscience News and Research

Scientists open door to significantly improved treatments for multiple sclerosis

Study shows worsened cognitive status associated with faster decline in functional abilities

New app to evaluate sports concussion

Study challenges role of serotonin in depression, opens possibilities for new therapies

Neuroscientists explain why some people with autism cannot recognize faces

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

Discovery could lead to new target for treatment of cocaine addiction

Telestroke programs improve access to life-saving stroke care

Alzheimer's research demonstrates cell-to-cell transmission of neurodegenerative proteins

Luminex collaborates with Merck to design companion diagnostic device for Alzheimer’s disease

Promising studies for Parkinson's to be presented at 65th AAN meeting

New hunt for intrinsic mechanism linked to schizophrenia

Researchers show inhibiting brain's filter can boost performance for tasks

Max Planck Florida Institute for Neuroscience gets grant for research into neurological disorders

Prescribing attention-boosting drugs for healthy kids is misguided

UH Case Medical Center joins elite group of providers focused on complex stroke care

GABA neuronal deficits in psychiatric disorder can be prevented using N-acetylcysteine: Study

Stimulating brain using magnetic stimulation may improve cognitive function, say scientists

Brain imaging can detect tiny lesions that may provide target for treating people with mTBI: Study

Biomedical professor details research progress toward reading, writing neural code

Neuroscience - Second Edition eBook

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News